Upcoming FDA APPROVALS : March April 2026 . : r biotech_stocks Dihexa for Women: Cognitive and Hormonal Health Benefits The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like The US FDA New Drug Approvals in April 2026 FDA's Overreach on Compounded Peptides FDA Announces Change in Status of 12 Peptides SSRP Institute